The document outlines a digitalization reference architecture for the pharmaceutical industry, focusing on technologies such as IoT, augmented reality, and cognitive computing. It aims to create transparency in technology usage, facilitate the integration of new IT suppliers, and enhance processes across drug development and patient care. The proposed architecture emphasizes synergies among various digital tools and offers a roadmap for implementing these technologies in the pharma sector.